News Conference News ESC 2017 CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events Michael O'Riordan August 27, 2017
News Daily News Hormone Therapies May Have Adverse CV Effects in Transgender Adults Ashley Lyles July 24, 2017
News Features Getting High: The Low-down for Cardiologists on Illicit Drugs and Marijuana Ashley Lyles July 13, 2017
News Conference News ACC 2017 Going to Low LDL Levels With Evolocumab Does Not Affect Memory, Brain Function: EBBINGHAUS Michael O'Riordan March 19, 2017
News Features Coalition of the Willing: PERTs Aim to Disentangle ‘Gordian Knot’ of Acute Pulmonary Embolism Todd Neale January 02, 2017